Bal Pharma Share Price Live
Live Bal Pharma Share Price Chart
O H L VOL
Bal Pharma Performance
Bal Pharma Shareholding Pattern
Data is not available currently. Please check back later.
Bal Pharma Fundamentals
ROCE(TTM) | 10.93 |
---|---|
P/E Ratio (TTM) | 25.32 |
P/B Ratio | 2.82 |
Industry P/E | 37.61 |
Debt to Equity | 2.25 |
ROE | 11.14 |
EPS (TTM) | 4.81 |
Dividend Yield | 0.98 |
Book Value | 43.21 |
Face Value | 10 |
ROCE(TTM) | 10.93 |
---|---|
P/E Ratio (TTM) | 25.32 |
P/B Ratio | 2.82 |
Industry P/E | 37.61 |
Debt to Equity | 2.25 |
ROE | 11.14 |
---|---|
EPS (TTM) | 4.81 |
Dividend Yield | 0.98 |
Book Value | 43.21 |
Face Value | 10 |
Bal Pharma Financials
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
---|---|---|---|---|
Net Sales | 81.66 | 94.63 | 74.36 | 73.69 |
Expenses | 76.83 | 87.19 | 70.32 | 68.48 |
Profit before tax | 1.27 | 5.75 | 0.62 | 1.36 |
Operating Profit | 0.85 | 5.53 | 0.26 | 1.04 |
Net Profit | 0.85 | 5.53 | 0.26 | 1.04 |
ESP in Rs | 0.54 | 3.73 | 0.16 | 0.65 |
Community Discussion
No comments found
Be the first one to start a discussion
Popular stocks
Bal Pharma Ltd FAQs
What is the share price of Bal Pharma Ltd (BALPHARMA) shares?
Bal Pharma Ltd (BALPHARMA) share price as of December 20, 2024, on NSE is Rs 120.85 (NSE) and Rs 120.85 (BSE) on BSE.
Can I buy Bal Pharma Ltd (BALPHARMA) from Angel One?
Yes, You can buy Bal Pharma Ltd (BALPHARMA) shares by opening a Demat account with Angel One.
How do I buy Bal Pharma Ltd (BALPHARMA) from Angel One?
Bal Pharma Ltd (BALPHARMA) share can be bought through the following modes:
1. Direct investment: You can buy Bal Pharma Ltd (BALPHARMA) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bal Pharma Ltd (BALPHARMA) shares.
1. Direct investment: You can buy Bal Pharma Ltd (BALPHARMA) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bal Pharma Ltd (BALPHARMA) shares.